Indication for biologic treatment in a real-world cohort of chronic rhinosinusitis patients according to international recommendations: Evidence from the European CRS outcome registry (CHRINOSOR).

Seys SF, Otten JJ, de Kinderen J, Bettio G, Andrianakis A, Alobid I, Cavaliere C, Hellings PW, Van Gerven L, Hox V, Hopkins C, Kjeldsen A, Schneider S, Tomazic PV, Diamant Z, Eckl-Dorna J, Fokkens WJ, Holzmeister C, Larsen K, Laulajainen-Hongisto A, Lund V, Mariën G, Masieri S, Mortuaire G, Moyaert M, Mullol J, Rodriguez van Strahlen C, de Vincentiis M, Wagenmann M, Reitsma S, Bachert C

Open source

DOI: 10.1016/j.waojou.2026.101365
Published: 2026 Apr
Container: The World Allergy Organization journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.waojou.2026.101365,
  title = {Indication for biologic treatment in a real-world cohort of chronic rhinosinusitis patients according to international recommendations: Evidence from the European CRS outcome registry (CHRINOSOR).},
  author = {Seys SF and Otten JJ and de Kinderen J and Bettio G and Andrianakis A and Alobid I and Cavaliere C and Hellings PW and Van Gerven L and Hox V and Hopkins C and Kjeldsen A and Schneider S and Tomazic PV and Diamant Z and Eckl-Dorna J and Fokkens WJ and Holzmeister C and Larsen K and Laulajainen-Hongisto A and Lund V and Mariën G and Masieri S and Mortuaire G and Moyaert M and Mullol J and Rodriguez van Strahlen C and de Vincentiis M and Wagenmann M and Reitsma S and Bachert C},
  year = {2026},
  journal = {The World Allergy Organization journal},
  doi = {10.1016/j.waojou.2026.101365},
  url = {https://doi.org/10.1016/j.waojou.2026.101365}
}

RIS

TY  - JOUR
TI  - Indication for biologic treatment in a real-world cohort of chronic rhinosinusitis patients according to international recommendations: Evidence from the European CRS outcome registry (CHRINOSOR).
AU  - Seys SF
AU  - Otten JJ
AU  - de Kinderen J
AU  - Bettio G
AU  - Andrianakis A
AU  - Alobid I
AU  - Cavaliere C
AU  - Hellings PW
AU  - Van Gerven L
AU  - Hox V
AU  - Hopkins C
AU  - Kjeldsen A
AU  - Schneider S
AU  - Tomazic PV
AU  - Diamant Z
AU  - Eckl-Dorna J
AU  - Fokkens WJ
AU  - Holzmeister C
AU  - Larsen K
AU  - Laulajainen-Hongisto A
AU  - Lund V
AU  - Mariën G
AU  - Masieri S
AU  - Mortuaire G
AU  - Moyaert M
AU  - Mullol J
AU  - Rodriguez van Strahlen C
AU  - de Vincentiis M
AU  - Wagenmann M
AU  - Reitsma S
AU  - Bachert C
PY  - 2026
JO  - The World Allergy Organization journal
DO  - 10.1016/j.waojou.2026.101365
UR  - https://doi.org/10.1016/j.waojou.2026.101365
ER  -

APA

SF, S., JJ, O., J, D. K., G, B., A, A., I, A., C, C., PW, H., L, V. G., V, H., C, H., A, K., S, S., PV, T., Z, D., J, E., WJ, F., C, H., K, L., A, L., V, L., G, M., S, M., G, M., M, M., J, M., C, R. V. S., M, D. V., M, W., S, R., & C, B. (2026). Indication for biologic treatment in a real-world cohort of chronic rhinosinusitis patients according to international recommendations: Evidence from the European CRS outcome registry (CHRINOSOR).. The World Allergy Organization journal. https://doi.org/10.1016/j.waojou.2026.101365

Source records

pubmed · retrieved 2026-09-26T05:17:38.512Z